Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer
World Journal of Surgery · 2026
DOI: 10.1002/wjs.70144 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Surgery, 2026. Verfasst von Marco Chiappetta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Unit, Magna Graecia University, Catanzaro, Italy. Hauptthemen laut MEDLINE: Lymph Node Excision, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Pneumonectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aim of this study is to evaluate the prognostic role of nodal parameter in early stage pathologically patients with N0 who underwent lobectomy and lymphadenectomy.
Methods
Clinical and pathological characteristics of patients who underwent anatomical lung resection from 1/01/2010 to 31/12/2019 were reviewed and retrospectively analyzed. GGO and part‐solid tumors, MIA, AIS, more than 5 cm in size, with nodal and/or distant metastases, or receiving neoadjuvant treatment were excluded. Operatory and pathological report were reviewed to collect data on lymphadenectomy. The primary end‐point was disease‐free survival (DFS), calculated from surgery to recurrence appearance. Clinical/pathological characteristics and nodal parameters were associate to DFS using Kaplan–Meier curves. The log‐rank test was used to assess differences between subgroups. A multivariable model was built using Cox‐regression analysis, including variable resulting significant ( p value < 0.05), at univariable analysis.
Results
The final analysis was conducted on 487 patients. Most patients presented stage I tumor (82.4%). The mean number of resected nodes (#RN), resected N1 (#RN1) nodes, and resected N2 nodes (#RN2) resulted 9.5 ± 8.0, 3.4 ± 4.3, and 5.9 ± 4.4. The mean number of total resected stations (#RS), N1 resected stations (#RSN1), and N2 resected stations (#RSN2) resulted 2.5 ± 1.6, 1 ± 0.8, and 1.5 ± 1.2, respectively. During a mean follow‐up of 43 ± 28 months, a recurrence occurred in 137 (28.1%) patients. At univariable analysis, age < 70 years ( p = 0.025), N1 lymphadenectomy ( p = 0.019), #RSN1 ≥ 3 ( p = 0.001), #RN ≥ 10 ( p = 0.019), #RN1 ≥ 3 ( p < 0.001), node sampling with more than 3 resected nodes ( p = 0.049), at least 3 stations with 3 N1 nodes resected ( p = 0.013), at least 3 stations resected with 10 lymphnodes, and 3N1 lymphnodes ( p = 0.020) significantly correlated with improved DFS. Multivariable analysis confirmed as independent prognostic factor #RN1 ≥ 3 ( p = 0.017; HR 1.782; and 95% CI: 1.107–2.867). Patients with #RN1 ≥ 3 presented a 5‐years DFS of 76.3% versus 57.8% of patients with #RN1 < 3 ( p = 0.001).
Conclusions
Hilar lymphadenectomy seems to significantly correlate with disease‐free survival in patients with pN0NSCLC and should be better defined in lymphadenectomy guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thoracic Surgery Unit, Magna Graecia University, Catanzaro, Italy.
- Thoracic Surgery Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- Thoracic Surgery Unit, Università Cattolica del Sacro Cuore, Rome, Italy.
- Biostatistical Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
ORCID-Profile: Marco Chiappetta, Carolina Sassorossi
Zitieren
APA
Chiappetta, M., Sassorossi, C., Lococo, F., Meacci, E., Congedo, M. T., Evangelista, J., Campanella, A., Calabrese, G., Senatore, A., Sperduti, I., & Margaritora, S. (2026). Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer. World Journal of Surgery. https://doi.org/10.1002/wjs.70144
Vancouver
Chiappetta M, Sassorossi C, Lococo F, Meacci E, Congedo MT, Evangelista J, et al. Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer. World Journal of Surgery. 2026. doi:10.1002/wjs.70144
BibTeX
@article{Chiappetta2026,
author = {Chiappetta, Marco and Sassorossi, Carolina and Lococo, Filippo and Meacci, Elisa and Congedo, Maria Teresa and Evangelista, Jessica and Campanella, Annalisa and Calabrese, Giuseppe and Senatore, Alessia and Sperduti, Isabella and Margaritora, Stefano},
title = {Hilar Lymphadenectomy Is Associated With Improved Disease‐Free Survival in Pathologically N0 Non‐Small Cell Lung Cancer},
journal = {World Journal of Surgery},
year = {2026},
doi = {10.1002/wjs.70144}
}
EUVIMED